Sessions are scheduled in local time (CEST)
Browsing Over 485 Presentations
Sort By
YO Clinical case discussion
Mentor guided discussion (ID 484)
Lecture Time
08:55 - 09:10
Session Name
Room
Frankfurt Hall
Date
Fri, 12.05.2023
Time
08:45 - 10:15
Speakers
- Nadia Harbeck (Munich, Germany)
Authors
- Nadia Harbeck (Munich, Germany)
Pfizer - Guiding light: Practical perspectives of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer
Navigating through clinical trial- and real world-based evidence (ID 152)
Lecture Time
19:30 - 19:30
Session Name
Room
Hamburg Hall
Date
Fri, 12.05.2023
Time
18:30 - 19:30
Speakers
- Richard S. Finn (Los Angeles, CA, United States of America)
Authors
- Richard S. Finn (Los Angeles, CA, United States of America)
Patient advocacy (Patient Advocates Working Group session)
European guidelines on breast cancer screening and diagnosis (ID 180)
Lecture Time
10:45 - 11:05
Room
Frankfurt Hall
Date
Sat, 13.05.2023
Time
10:45 - 12:15
Speakers
- Gian Paolo Morgano (Ispra, Italy)
Authors
- Gian Paolo Morgano (Ispra, Italy)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer
Q&A and closing remarks (ID 11)
Lecture Time
19:25 - 19:30
Session Name
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
- Diana I. Luftner (Brandenburg an der Havel, Germany)
Authors
- Diana I. Luftner (Brandenburg an der Havel, Germany)
MSD - Perspectives on the treatment of HER2-negative gBRCAm early breast cancer
Evolving treatment landscape in HER2-negative gBRCAm patients (ID 43)
Lecture Time
19:30 - 19:50
Room
Munich Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
- Karen A. Gelmon (Vancouver, BC, Canada)
Authors
- Karen A. Gelmon (Vancouver, BC, Canada)
Utility of real-world data
Quality, cost and survival: Can real-world data help to solve the equation? (ID 76)
Lecture Time
11:05 - 11:25
Session Name
Room
Munich Hall
Date
Fri, 12.05.2023
Time
10:45 - 12:15
Speakers
- Marina Borges (Porto, Portugal)
Authors
- Marina Borges (Porto, Portugal)
Bringing the patient voice to cancer research (GRASP session)
Formation of the Lobular Breast Cancer Alliance and Pittsburgh's rapid autopsy programme in coordination with patient advocates (ID 114)
Lecture Time
15:00 - 15:15
Room
Frankfurt Hall
Date
Fri, 12.05.2023
Time
14:45 - 16:00
Speakers
- Steffi Oesterreich (Pittsburgh, PA, United States of America)
Authors
- Steffi Oesterreich (Pittsburgh, PA, United States of America)
F. Hoffmann-La Roche - PI3King the right treatment for every patient with HR+ breast cancer
Introduction (ID 147)
Lecture Time
18:30 - 18:30
Session Name
Room
Munich Hall
Date
Fri, 12.05.2023
Time
18:30 - 19:30
Speakers
- Sibylle Loibl (Neu-Isenburg, Germany)
Authors
- Sibylle Loibl (Neu-Isenburg, Germany)
ESMO Breast 2023 key takeaways
Translational research (ID 175)
Lecture Time
10:45 - 11:05
Session Name
Room
Berlin Hall
Date
Sat, 13.05.2023
Time
10:45 - 12:15
Speakers
- Christine Desmedt (Leuven, Belgium)
Authors
- Christine Desmedt (Leuven, Belgium)
Pierre Fabre - Are we improving the odds of surviving cancer? Optimizing adjuvant therapy in HER2+ breast cancer
Welcome and introduction (ID 6)
Lecture Time
18:30 - 18:35
Session Name
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
- Diana I. Luftner (Brandenburg an der Havel, Germany)
Authors
- Diana I. Luftner (Brandenburg an der Havel, Germany)
Daiichi Sankyo - Key targets for ADC directed therapy in breast cancer
Introduction (ID 38)
Lecture Time
18:30 - 18:35
Room
Hamburg Hall
Date
Thu, 11.05.2023
Time
18:30 - 19:30
Speakers
- Ian Krop (New Haven, United States of America)
Authors
- Ian Krop (New Haven, United States of America)
Micrometastatic node positive disease should be considered as node-negative for systemic treatment decisions
Introduction and first vote (ID 71)
Lecture Time
09:00 - 09:10
Session Name
Room
Hamburg Hall
Date
Fri, 12.05.2023
Time
09:00 - 10:00
Speakers
- Peter Dubsky (Luzern, Switzerland)
Authors
- Peter Dubsky (Luzern, Switzerland)